IR contact

The principle task of Immunovia´s Investor Relations is to provide investors and the capital market with accurate, relevant and timely information that facilitates an understanding of the operations of Immunova AB.

Contact Investor Relations for details:
Patrik Dahlen, CEO Immunovia


Tel: +46 73 376 76 64

You are also welcome to ask your question or make your request by:


Subscribe to receive press releases and reports via email
To start your subscription you need to activate your e-mail address by clicking the link in the email that is sent to you after you have submitted this form. Please check the junk mail if you cannot find the message.

Press releases
Financial reports